| Product NDC: | 17478-792 |
| Proprietary Name: | Akten |
| Non Proprietary Name: | lidocaine hydrochloride |
| Active Ingredient(s): | 35 mg/mL & nbsp; lidocaine hydrochloride |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | GEL |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 17478-792 |
| Labeler Name: | Akorn, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022221 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20081008 |
| Package NDC: | 17478-792-10 |
| Package Description: | 1 BOTTLE, DROPPER in 1 CARTON (17478-792-10) > 5 mL in 1 BOTTLE, DROPPER |
| NDC Code | 17478-792-10 |
| Proprietary Name | Akten |
| Package Description | 1 BOTTLE, DROPPER in 1 CARTON (17478-792-10) > 5 mL in 1 BOTTLE, DROPPER |
| Product NDC | 17478-792 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | lidocaine hydrochloride |
| Dosage Form Name | GEL |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 20081008 |
| Marketing Category Name | NDA |
| Labeler Name | Akorn, Inc. |
| Substance Name | LIDOCAINE HYDROCHLORIDE |
| Strength Number | 35 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Antiarrhythmic [EPC],Local Anesthesia [PE] |